Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03368794

Naloxone to TReatment Entry in the Emergency Setting

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Anders C Håkansson · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study tests a structured referral process for opioid overdose survivors, from pre-hospital emergency care to long-term treatment of the individual's substance use-related disorder.

Detailed description

Randomized controlled trial. Subjects are included if they are being treated by an ambulance in the Malmö uptake are for an opioid overdose requiring naloxone antidote administration, and if they sign informed written consent to the study. Subjects are randomized by ambulance staff to either an active intervention, or a control condition: Intervention: A telephone alert signal is sent from ambulance staff after successful naloxone reversal of an opioid overdose, leading to an active outreach effort from the staff of the addiction research facility, where staff locate the individual and offer her/him formal inclusion in the study. Control: No telephone alert signal is sent, and the active outreach procedure is not carried out. Ambulance staff hand over written information to the individual about how she/he can apply actively for treatment. Primary outcome is entry into formal assessment and treatment of the substance use disorder.

Conditions

Interventions

TypeNameDescription
BEHAVIORALActive treatment referral of opioid overdose survivors to long-term treatmentTelephone alert and outreach for inclusion, assessment and intake into long-term evidence-based treatment of the substance use disorder.
BEHAVIORALControlWritten information from ambulance staff to the patient about how to seek treatment. Patient is able to contact the research treatment facility through a specific phone number, making it possible to study treatment entry in the information-only control condition.

Timeline

Start date
2017-09-15
Primary completion
2021-03-12
Completion
2021-03-12
First posted
2017-12-11
Last updated
2021-03-16

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03368794. Inclusion in this directory is not an endorsement.